Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-03-03 @ 5:25 PM
Study NCT ID:
NCT02281318
Status:
COMPLETED
Last Update Posted:
2018-08-06
First Post:
2014-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-30
First Submit QC Date:
None
Study First Post Date:
2014-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-05
Results First Submit QC Date:
None
Results First Post Date:
2017-05-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-02
Last Update Post Date:
2018-08-06
Last Update Post Date Type:
ACTUAL